LTRN Lantern Pharma Inc.
Fundamentals / CIK 0001763950 / USDLantern Pharma Inc. reported $8.52M in total assets and a net loss of $13.78M through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open LTRN in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$16.49M Operating profit
-
Net Income FY 2025-$13.78M GAAP bottom line
-
Diluted EPS FY 2025-$1.01 Split-adjusted
-
Free Cash Flow FY 2025-$15.68M Operating CF less CapEx
-
Cash & ST Investments Sep 30, 2026$7.63M Total debt: $47K
Annual revenue and net income
7 fiscal years (2019 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Research & Development | $11.51M | $16.13M | $11.89M | $8.60M | $7.57M | $2.24M | -- |
| Total Operating Expenses | $17.98M | $22.22M | $17.88M | $14.43M | $12.59M | $5.91M | $2.43M |
| Operating Income | -$17.98M | -$22.22M | -$17.88M | -$14.43M | -$12.59M | -- | -- |
| EBITDA | -$17.96M | -$22.20M | -$17.86M | -$14.42M | -$12.58M | -- | -- |
| Interest Income | $438K | $742K | $765K | $204K | $68K | -- | -- |
| Net Income | -$17.12M | -$20.78M | -$15.96M | -$14.26M | -$12.36M | -$5.91M | -$2.43M |
| Basic EPS | -$1.57 | -$1.93 | -$1.47 | -$1.31 | -$1.13 | -$1.37 | -$1.23 |
| Diluted EPS | -$1.57 | -$1.93 | -$1.47 | -$1.31 | -$1.13 | -$1.37 | -$1.23 |
| Basic Shares Outstanding | 10.9M | 10.8M | 10.8M | 10.9M | 10.9M | 4.3M | 2.0M |
| Diluted Shares Outstanding | 10.9M | 10.8M | 10.8M | 10.9M | 10.9M | 4.3M | 2.0M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $1.57M | $1.79M | $1.72M | $2.74M | $2.44M | $3.07M | $3.26M | $4.27M |
| Total Operating Expenses | $5.38M | $3.51M | $3.41M | $4.20M | $4.35M | $4.65M | $4.77M | $5.90M |
| Operating Income | -$5.38M | -$3.51M | -$3.41M | -$4.20M | -$4.35M | -$4.65M | -$4.77M | -$5.90M |
| EBITDA | -$5.37M | -$3.50M | -$3.40M | -$4.20M | -$4.35M | -$4.65M | -$4.77M | -$5.89M |
| Interest Income | $27K | $30K | $42K | $72K | $101K | $115K | $150K | $161K |
| Net Income | $697K | -$7.07M | -$3.33M | -$4.07M | -$4.18M | -$4.33M | -$4.54M | -$5.88M |
| Basic EPS | $0.05 | -$0.57 | -$0.30 | -- | -$0.39 | -$0.40 | -$0.42 | -- |
| Diluted EPS | -$0.37 | -$0.57 | -$0.30 | -- | -$0.39 | -$0.40 | -$0.42 | -- |
| Basic Shares Outstanding | 13.5M | 12.4M | 11.3M | -- | 10.8M | 10.8M | 10.8M | -- |
| Diluted Shares Outstanding | 13.6M | 12.4M | 11.3M | -- | 10.8M | 10.8M | 10.8M | -- |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $4.42M | $7.51M | $21.94M | $37.20M | $51.52M | $19.23M | $1.23M |
| Short-Term Investments | $5.70M | $16.50M | $19.36M | $17.99M | $19.20M | -- | -- |
| Cash & Short-Term Investments | $10.12M | $24.01M | $41.30M | $55.20M | $70.73M | $19.23M | $1.23M |
| Total Current Assets | $10.80M | $25.25M | $43.34M | $58.72M | $72.72M | $20.24M | $1.23M |
| Property, Plant & Equipment, Net | $32K | $47K | $52K | $48K | $30K | $22K | $8.8K |
| Other Non-Current Assets | $37K | $37K | $26K | $18K | $18K | -- | -- |
| Total Non-Current Assets | $233K | $324K | $306K | $114K | $1.23M | $123K | $200K |
| Total Assets | $11.04M | $25.57M | $43.65M | $58.84M | $73.95M | $20.36M | $1.43M |
| Accounts Payable | -- | -- | -- | -- | -- | $108K | -- |
| Total Current Liabilities | $4.50M | $4.33M | $2.68M | $2.80M | $2.33M | $552K | $489K |
| Total Non-Current Liabilities | $0 | $53K | $61K | $0 | $53K | $108K | $0 |
| Total Liabilities | $4.50M | $4.38M | $2.74M | $2.80M | $2.38M | $661K | $489K |
| Total Debt (incl. Leases) | $79K | $244K | $234K | $53K | $205K | -- | -- |
| Common Stock | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $622 | $198 |
| Retained Earnings | -$93.15M | -$76.03M | -$55.24M | -$39.28M | -$25.02M | -$12.66M | -$6.75M |
| Accumulated Other Comp. Income | $25K | $154K | -$107K | -$371K | -$93K | -- | -- |
| Total Stockholders' Equity | $6.53M | $21.19M | $40.91M | $56.04M | $71.57M | $19.70M | $943K |
| Total Equity | $6.53M | $21.19M | $40.91M | $56.04M | $71.57M | $19.70M | $943K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $7.62M | $6.66M | $4.92M | $4.42M | $8.39M | $6.06M | $6.38M | $7.51M |
| Short-Term Investments | $11K | $701K | $1.41M | $5.70M | $3.97M | $9.84M | $13.34M | $16.50M |
| Cash & Short-Term Investments | $7.63M | $7.36M | $6.32M | $10.12M | $12.36M | $15.90M | $19.72M | $24.01M |
| Total Current Assets | $8.41M | $8.46M | $7.06M | $10.80M | $13.46M | $17.20M | $20.82M | $25.25M |
| Property, Plant & Equipment, Net | $21K | $24K | $28K | $32K | $36K | $40K | $44K | $47K |
| Other Non-Current Assets | $26K | $26K | $26K | $37K | $37K | $37K | $37K | $37K |
| Total Non-Current Assets | $111K | $143K | $166K | $233K | $166K | $220K | $273K | $324K |
| Total Assets | $8.52M | $8.60M | $7.22M | $11.04M | $13.63M | $17.42M | $21.10M | $25.57M |
| Total Current Liabilities | $5.65M | $4.32M | $3.78M | $4.50M | $4.04M | $4.88M | $4.29M | $4.33M |
| Total Non-Current Liabilities | $1.46M | $7.50M | $0 | $0 | $0 | $14K | $33K | $53K |
| Total Liabilities | $7.11M | $11.82M | $3.78M | $4.50M | $4.04M | $4.90M | $4.32M | $4.38M |
| Total Debt (incl. Leases) | $47K | $40K | $59K | $79K | $94K | $145K | $59K | $244K |
| Common Stock | $1.5K | $1.3K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K | $1.1K |
| Retained Earnings | -$102.8M | -$103.5M | -$96.47M | -$93.15M | -$89.07M | -$84.89M | -$80.56M | -$76.03M |
| Accumulated Other Comp. Income | -$46K | -$40K | -$36K | $25K | $40K | $48K | $132K | $154K |
| Total Stockholders' Equity | $1.41M | -$3.22M | $3.45M | $6.53M | $9.59M | $12.52M | $16.78M | $21.19M |
| Total Equity | $1.41M | -$3.22M | $3.45M | $6.53M | $9.59M | $12.52M | $16.78M | $21.19M |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Net Income | -$17.12M | -$20.78M | -$15.96M | -$14.26M | -$12.36M | -$5.91M | $2.43M |
| Depreciation & Amortization | $17K | $17K | $15K | $10K | $6.8K | $3.4K | $1.6K |
| Stock-Based Compensation | $651K | $652K | $1.02M | $1.19M | $962K | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -$169K | -- |
| Operating Cash Flow | -$15.68M | -$17.81M | -$14.35M | -$12.77M | -$10.59M | -$5.65M | -$2.13M |
| Capital Expenditure | -$1.7K | -$13K | -$19K | -$28K | -$15K | -- | -- |
| Free Cash Flow | -$15.68M | -$17.83M | -$14.37M | -$12.80M | -$10.61M | -- | -- |
| Purchases of Investments | -$14.72M | -$17.28M | -$8.20M | -$3.91M | -$19.58M | -- | -- |
| Investing Cash Flow | $11.06M | $3.37M | -$930K | $179K | -$19.53M | -$16K | -$5.7K |
| Common Stock Issued | $1.62M | -- | -- | -- | $69.00M | -- | -- |
| Share Repurchases | -- | -- | -$500K | -$2.48M | -$940K | -- | -- |
| Financing Cash Flow | $1.50M | $67K | -$500K | -$2.18M | $63.42M | $23.66M | $2.92M |
| Net Change in Cash | -$3.09M | -$14.43M | -$15.81M | -$14.78M | $33.30M | $18.00M | $787K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Net Income | $697K | -$7.07M | -$3.33M | -$4.07M | -$4.18M | -$4.33M | -$4.54M | -$5.88M |
| Depreciation & Amortization | $3.5K | $3.8K | $3.9K | $4.1K | $4.1K | $4.5K | $4.6K | $4.6K |
| Stock-Based Compensation | -- | -- | -- | $199K | $144K | $161K | $148K | $205K |
| Operating Cash Flow | -$3.34M | -$2.94M | -$3.77M | -$2.79M | -$4.57M | -$3.94M | -$4.38M | -$3.97M |
| Capital Expenditure | -- | -- | -- | -$1 | -$555 | $0 | -$1.2K | -$3.1K |
| Free Cash Flow | -- | -- | -- | -$2.79M | -$4.57M | -$3.94M | -$4.38M | -$3.97M |
| Purchases of Investments | -- | -- | -- | -$4.20M | -$2.08M | -$3.46M | -$4.98M | $201K |
| Investing Cash Flow | $672K | $692K | $4.25M | -$1.70M | $5.93M | $3.59M | $3.24M | $3.45M |
| Common Stock Issued | $31K | -- | -- | -- | $31K | -- | -- | -- |
| Financing Cash Flow | -- | -- | -- | -- | -- | -- | -- | $0 |
| Net Change in Cash | $956K | $1.74M | $495K | -$3.97M | $2.33M | -$316K | -$1.13M | -$592K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -262.0% | -98.1% | -39.0% | -25.4% | -17.3% | -30.0% | -257.4% |
| Return on Assets (ROA) | -155.1% | -81.3% | -36.6% | -24.2% | -16.7% | -29.0% | -169.5% |
| Current Ratio | 2.40x | 5.83x | 16.18x | 20.99x | 31.26x | 36.64x | 2.52x |
| Quick Ratio | 2.25x | 5.54x | 15.42x | 19.72x | 30.40x | 34.81x | 2.52x |
| Debt to Equity | 0.01x | 0.01x | 0.01x | 0.00x | 0.00x | -- | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -977.1% | -- | -461.8% | -262.0% | -197.4% | -153.7% | -118.5% | -98.1% |
| Return on Assets (ROA) | -161.6% | -216.8% | -220.3% | -155.1% | -138.8% | -110.5% | -94.2% | -81.3% |
| Current Ratio | 1.49x | 1.96x | 1.87x | 2.40x | 3.33x | 3.52x | 4.86x | 5.83x |
| Quick Ratio | 1.35x | 1.70x | 1.67x | 2.25x | 3.06x | 3.26x | 4.60x | 5.54x |
| Debt to Equity | 0.03x | -- | 0.02x | 0.01x | 0.01x | 0.01x | 0.00x | 0.01x |